LC–MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma-Reference-Cited by-同舟云学术

LC–MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma

Published:2017-11 Issue: Volume:146 Page:154-160
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Matsumoto Julia,Kiesel Brian F.,Parise Robert A.,Guo Jianxia,Taylor Sarah,Huang Marilyn,Eiseman Julie L.,Ivy S. Percy,Kunos Charles,Chu Edward,Beumer Jan H.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference20 articles.

1. Cancer statistics, 2015;Siegel;CA: Cancer J. Clin.,2015

2. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis;Wang;Arch. Gynecol. Obstet.,2011

3. I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer;Kunos;Clin. Cancer Res.,2010

4. Iron-targeting antitumor activity of gallium compounds and novel insights into triapine((R))-metal complexes;Chitambar;Antioxid. Redox Signal.,2013

5. Ironing out cancer;Torti;Cancer Res.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of an LC–MS/MS generic assay platform for small molecule drug bioanalysis;Journal of Pharmaceutical and Biomedical Analysis;2021-09

2. In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine;Cancer Chemotherapy and Pharmacology;2020-09-28

3. Synthesis, anticancer activity and mechanism of iron chelator derived from 2,6-diacetylpyridine bis(acylhydrazones);Journal of Inorganic Biochemistry;2019-04